Global Viscosupplementation Industry, spurred by increasing arthritis prevalence, eyes a value of US$ 2.89 Billion by 2030 | FMI

Viscosupplementation Industry
Viscosupplementation Industry

As per comprehensive market analysis and research, the viscosupplementation industry size is expected to witness substantial growth, reaching a value of US$ 2.89 billion by 2030. This prediction marks a significant increase from its estimated worth of US$ 1.98 billion in 2022.

The global viscosupplementation market is forecasted to expand at a Compound Annual Growth Rate (CAGR) of 4.8% from its current standing, highlighting a continuous upward trajectory in demand and market reach. This anticipated growth is attributed to various factors, including increasing awareness about advanced treatment options, rising incidences of osteoarthritis, and ongoing advancements in medical technology and product development.

Get Your Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

There are millions of people suffering from joint discomfort in the world. It can drastically reduce movement and worsen quality of life while also creating discomfort. However, Viscosupplementation Market, a cutting-edge therapy alternative, is now accessible because to developments in medical technology. This novel strategy has received a lot of attention recently and is revolutionising how we treat joint pain.

To reduce pain and enhance joint function, viscosupplementation involves injecting hyaluronic acid (HA) into the troubled joint. Synovial fluid, which lubricates and cushions joints, contains hyaluronic acid, a naturally occurring molecule. The concentration of HA falls in people with osteoarthritis, which exacerbates joint damage and pain.

This market, which has been relatively less affected by COVID-19-induced sluggishness, will increase as a result of a combination of general and industry-specific causes, the report claims. The UN predicts that by 2050, people 60 and older will make up more than 20% of the world’s population. In other words, the UN estimates that 130 million people will have osteoarthritis by 2050. These numbers suggest that during the projection period, the viscosupplementation market will grow.

Key Takeaways of Viscosupplementation Market Study:

  • Three injection viscosuppplementation is expected to contribute for more than 55% of revenue share
  • Knee osteoarthritis is expected to gain around one-third of market share during the forecast period
  • North America is the highest revenue generating market due to scientific advancements and high adoption of viscosuppplementation

If You Have Any Questions, Feel Free To Reach Out To Our Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-9509

Some Of The Innovations Are:

  • Fidia Pharma USA Inc., in 2019, introduced a HA (Hyaluronic Acid) based intra-articular viscosupplement called “TRILURON” to treat knee osteoarthritis. The treatments cycle involves 3 injections at weekly intervals.
  • Japan-based Seikagaku Corporation, in Mar 2019, launched an intra-articular single-injection viscosupplement called “HyLink” in Italy for treating knee osteoarthritis.
  • Recently, Gel-One Hyaluronate was approved as one of the injectable gels to treat osteoarthritis of knee. The pre-market clinical study reported no pseudosepsis (severe acute inflammatory responses).

Top Key Players Covered:

  • Sanofi S.A.
  • Zimmer Biomet Holdings Inc.
  • Bioventus LLC
  • Anika Therapeutics Inc.
  • Fidia Farmaceutici S.p.A.
  • Ferring B.V.
  • Seikagaku Corporation
  • Chugai Pharmaceutical Co., Ltd.
  • OrthogenRx Inc.
  • Mylan N.V.

The Ultimate Guide to Customization: Unveiling the Secrets in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-9509

Key Segments of Viscosupplementation Industry Survey:

Viscosupplementation Market by Product:

  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation

Viscosupplementation Market by Application:

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Shoulder Osteoarthritis
  • Others

Viscosupplementation Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics
  • Retail Pharmacies
  • Online Sales

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Ronak Shah

Associate Vice President at Future Market Insights is deeply committed to uncovering actionable insights for consumer and food and beverage players. She brings a unique blend of analysis, industry trends, and consumer behavior to put data into perspective.

What she makes out of data becomes a delight to read. She has authored many opinions, including for publications like Process Industry Informer and Spinal Surgery News, as she understands the market pulse and consumers' shifting preferences.

She likes to bring experts to a roundtable to weigh the impact of a trend on an industry. Catch up with her discussion on the impact of AI in packaging.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these